This episode will premiere on Saturday, April 23, at 6 p.m. ET! “We have seen the ultimate demise of our health care system when it’s in the hands of bureaucrats,” says Dr. Richard Urso, a co-founder of the International Alliance of Physicians and Medical Scientists. Previously, in part one of our interview, we discussed alarming…
[PREMIERING 4/23 at 6PM ET] PART 2: Dr. Richard Urso: Big Pharma Makes Billions by Rebranding Existing Drugs as ‘New’ Products
April 20, 2022
admin
American Thought LeadersCCP VirusCOVID-19dr. richard ursoEpochTVExpert ViewInternational Alliance of Physicians and Medical ScientistsPaxlovidPublic HealthUS
0 Comment
China Approves Pfizer’s Oral COVID Drug, Swift Imports and Deployment Follow
Chinese state-owned Meheco Group signed a deal in mid-March with Pfizer to be its mainland China partner for the commercialization of Paxlovid, an oral COVID-19 drug that obtained conditional approval from China’s National Medical Products Administration (NMPA) earlier this year. In less than a week, the first batch, 20,000 doses of Paxlovid, cleared customs and…
35 Global Firms to Produce Pfizer’s Oral COVID Drug for Low-Income Countries
The U.N.-backed Medicines Patent Pool (MPP) said Thursday that 35 global firms have agreed to manufacture the generic version of Pfizer’s oral COVID-19 drug, Paxlovid, for distribution in 95 low-and middle-income countries. Paxlovid is a combination of two antiviral drugs–nirmatrelvir, which blocks the virus from replicating, and ritonavir–which slows down nirmatrelvir’s breakdown to help it…
Japan Grants Fast-Track Approval for Pfizer’s Oral COVID-19 Drug
Japan’s Health Ministry on Thursday granted fast-track approval for Pfizer’s oral COVID-19 drug, Paxlovid, to treat patients with mild symptoms amid the rapid spread of the coronavirus fueled by the Omicron variant in the country. The ministry said in a statement that it has secured 2 million courses of treatment with the U.S.-based drugmaker Pfizer,…
EU Approves Pfizer’s COVID-19 Pill for Adults at Risk of Severe Disease
The European Commission (EC) on Friday authorized the use of Pfizer’s COVID-19 antiviral pill one day after the European Unions’ (EU) drugs regulator backed the treatment for adults who do not require supplemental oxygen and who are at increased risk of severe disease. Stella Kyriakides, the EU’s commissioner for health and food safety, called it “a key…
Australia Approves Novavax COVID-19 Vaccine and New COVID Oral Drug Treatments
January 19, 2022
admin
AustraliaAustralian Technical Advisory Group on ImmunisationCCP VirusCOVID-19 vaccineGreg HuntInternationalLagevrioNovavaxoral pillsPaxlovidPfizerTherapeutic Goods AdministrationVaccines & SafetyWorld
0 Comment
The national drug regulator has given the green light to the Novavax vaccine, along with two oral treatments for patients currently suffering from COVID-19. The Therapeutic Goods Administration (TGA) on Thursday approved the Novavax vaccine, also called Nuvaxovid, for adults aged 18 years and over, making it the first protein-based COVID-19 vaccine in the country’s…
Health Canada Approves Pfizer Antiviral
OTTAWA—Health Canada has approved Pfizer’s antiviral treatment for COVID-19. The authorization posted to the Health Canada website this morning says the treatment is greenlighted for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not authorize it for use on teenagers. It is…
Biden Moves to Double the Government’s Order of New Pfizer COVID-19 Pill
President Joe Biden Tuesday directed the federal government to double its purchase of Pfizer’s oral antiviral treatment, Paxlovid. This addition increases the U.S. total purchase from Pfizer from 10 million to 20 million therapeutic courses of the new pill. The U.S. Food and Drug Administration (FDA) authorized the emergency use of Paxlovid last month for…
New York State Health Dept. Warns Not Enough Paxlovid or Molnupiravir Antibody Treatment
The New York State Health Department has warned that it does not have enough Paxlovid or Molnupiravir antibody treatment and authorized those of non-white race or Hispanic/Latino ethnicity, as well as individuals with underlying medical conditions that increase their risk for severe illness, to receive the treatment. However, the government body made no mention of whether or not other…
COVID Antiviral Pills Cause Life-Threatening Reactions When Used With Many Common Meds: FDA
Pfizer’s antiviral oral drug developed to treat COVID-19 can cause severe or life-threatening effects when used with common medications including some anti-coagulants, some anti-depressants, and some cholesterol-lowering statins, according to the Food and Drug Administration (FDA) (pdf). FDA does not recommend Paxlovid for those with severe kidney or liver disease. The FDA on Dec. 22 granted emergency…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`